Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection

被引:9
作者
Kali, Suresh Kumar [1 ]
Droge, Peter [2 ]
Murugan, Priyatharshini [2 ]
机构
[1] Bharathidasan Univ, Dept Biotechnol, Tiruchirappalli, India
[2] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore
关键词
Coronavirus disease 2019; Severe acute respiratory syndrome; Type I Interferon; Innate immunity; Interferon beta monotherapy; GENE-EXPRESSION; COVID-19; RIBAVIRIN; COMBINATION; INDUCTION; BINDING; EVASION; PROTEIN; TMPRSS2; CELLS;
D O I
10.1016/j.micpath.2021.105105
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
COVID-19 exhibits a global health threat among the elderly and the population with underlying health conditions. During infection, the host's innate immune response acts as a frontline of defense by releasing cytokines such as type I interferon (IFN alpha and beta) thereby initiating antiviral activity. However, this particular interferon response is interrupted by factors such as SARS-CoV-2 non-structural proteins, aging, diabetes, and germ-line errors eventually making the host more susceptible to illness. Therefore, enhancing the host's innate immune response by administering type I IFN could be an effective treatment against COVID-19. Here, we highlight the importance of innate immune response and the role of IFN beta monotherapy against COVID-19.
引用
收藏
页数:10
相关论文
共 99 条
[1]   Interferon Beta: From Molecular Level to Therapeutic Effects [J].
Abdolvahab, M. Haji ;
Mofrad, M. R. K. ;
Schellekens, H. .
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 326, 2016, 326 :343-372
[2]   Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome [J].
Arabi, Yaseen M. ;
Asiri, Ayed Y. ;
Assiri, Abdullah M. ;
Balkhy, Hanan H. ;
Al Bshabshe, Ali ;
Al Jeraisy, Majed ;
Mandourah, Yasser ;
Azzam, Mohamed H. A. ;
Bin Eshaq, Abdulhadi M. ;
Al Johani, Sameera ;
Al Harbi, Shmeylan ;
Jokhdar, Hani A. A. ;
Deeb, Ahmad M. ;
Memish, Ziad A. ;
Jose, Jesna ;
Ghazal, Sameeh ;
Al Faraj, Sarah ;
Al Mekhlafi, Ghaleb A. ;
Sherbeeni, Nisreen M. ;
Elzein, Fatehi E. ;
Al-Hameed, Fahad ;
Al Saedi, Asim ;
Alharbi, Naif K. ;
Fowler, Robert A. ;
Hayden, Frederick G. ;
Al-Dawood, Abdulaziz ;
Abdelzaher, Mohamed ;
Bajhmom, Wail ;
AlMutairi, Badriah M. ;
Hussein, Mohamed A. ;
Alothman, Adel .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) :1645-1656
[3]   Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans [J].
Arunachalam, Prabhu S. ;
Wimmers, Florian ;
Mok, Chris Ka Pun ;
Perera, Ranawaka A. P. M. ;
Scott, Madeleine ;
Hagan, Thomas ;
Sigal, Natalia ;
Feng, Yupeng ;
Bristow, Laurel ;
Tsang, Owen Tak-Yin ;
Wagh, Dhananjay ;
Coller, John ;
Pellegrini, Kathryn L. ;
Kazmin, Dmitri ;
Alaaeddine, Ghina ;
Leung, Wai Shing ;
Chan, Jacky Man Chun ;
Chik, Thomas Shiu Hong ;
Choi, Chris Yau Chung ;
Huerta, Christopher ;
McCullough, Michele Paine ;
Lv, Huibin ;
Anderson, Evan ;
Edupuganti, Srilatha ;
Upadhyay, Amit A. ;
Bosinger, Steve E. ;
Maecker, Holden Terry ;
Khatri, Purvesh ;
Rouphael, Nadine ;
Peiris, Malik ;
Pulendran, Bali .
SCIENCE, 2020, 369 (6508) :1210-+
[4]   Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha [J].
Barbaro, G ;
Di Lorenzo, G ;
Soldini, M ;
Giancaspro, G ;
Pellicelli, A ;
Grisorio, B ;
Babarini, G .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (09) :928-933
[5]   Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [J].
Bastard, Paul ;
Rosen, Lindsey B. ;
Zhang, Qian ;
Michailidis, Eleftherios ;
Hoffmann, Hans-Heinrich ;
Zhang, Yu ;
Dorgham, Karim ;
Philippot, Quentin ;
Rosain, Jeremie ;
Beziat, Vivien ;
Manry, Jeremy ;
Shaw, Elana ;
Haljasmagi, Liis ;
Peterson, Part ;
Lorenzo, Lazaro ;
Bizien, Lucy ;
Trouillet-Assant, Sophie ;
Dobbs, Kerry ;
de Jesus, Adriana Almeida ;
Belot, Alexandre ;
Kallaste, Anne ;
Catherinot, Emilie ;
Tandjaoui-Lambiotte, Yacine ;
Le Pen, Jeremie ;
Kerner, Gaspard ;
Bigio, Benedetta ;
Seeleuthner, Yoann ;
Yang, Rui ;
Bolze, Alexandre ;
Spaan, Andras N. ;
Delmonte, Ottavia M. ;
Abers, Michael S. ;
Aiuti, Alessandro ;
Casari, Giorgio ;
Lampasona, Vito ;
Piemonti, Lorenzo ;
Ciceri, Fabio ;
Bilguvar, Kaya ;
Lifton, Richard P. ;
Vasse, Marc ;
Smadja, David M. ;
Migaud, Melanie ;
Hadjadj, Jerome ;
Terrier, Benjamin ;
Duffy, Darragh ;
Quintana-Murci, Lluis ;
van de Beek, Diederik ;
Roussel, Lucie ;
Vinh, Donald C. ;
Tangye, Stuart G. .
SCIENCE, 2020, 370 (6515) :423-+
[6]   COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection [J].
Beyerstedt, Stephany ;
Casaro, Expedito Barbosa ;
Rangel, Erika Bevilaqua .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) :905-919
[7]   SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients [J].
Bizzotto, Juan ;
Sanchis, Pablo ;
Abbate, Mercedes ;
Lage-Vickers, Sofia ;
Lavignolle, Rosario ;
Toro, Ayelen ;
Olszevicki, Santiago ;
Sabater, Agustina ;
Cascardo, Florencia ;
Vazquez, Elba ;
Cotignola, Javier ;
Gueron, Geraldine .
ISCIENCE, 2020, 23 (10)
[8]   Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 [J].
Blanco-Melo, Daniel ;
Nilsson-Payant, Benjamin E. ;
Liu, Wen-Chun ;
Uhl, Skyler ;
Hoagland, Daisy ;
Moller, Rasmus ;
Jordan, Tristan X. ;
Oishi, Kohei ;
Panis, Maryline ;
Sachs, David ;
Wang, Taia T. ;
Schwartz, Robert E. ;
Lim, Jean K. ;
Albrecht, Randy A. ;
tenOever, Benjamin R. .
CELL, 2020, 181 (05) :1036-+
[9]  
Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
[10]   Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C [J].
Chan, Henry L. Y. ;
Ren, Hong ;
Chow, Wan C. ;
Wee, Theodore .
HEPATOLOGY, 2007, 46 (02) :315-323